Use of a Schelin Catheter for analgesia during Rezum treatment of the prostate

The efficacy and safeness of Rezum treatment (RT) is widely described in literature for patients with moderate LUTS [1–4]. Despite initial concerns about indication in glands over 80 ml of volume and third lobe, Elterman et al. have just presented their 1-year outcomes after RT in 83 patients with median (IQR) prostate volume of 100 ml (88.5–115.0), 65% with median lobe.

Click here to download full Article